Study Reveals, New Drug Might Impede Chronic Thyroid Cancer

February 13, 2015 7:21 PM

13 0

As per the results from a new clinical trial, a new thyroid cancer medicine can impede the progression of the disease about five times longer than a placebo in individuals with chronic cancer.

The oral medication, lenvatinib, is a targeted treatment that fights cancer by preventing the development of new blood vessels that could help encourage the cancer, scientists said.

Read more

To category page